U.S. flag

An official website of the United States government

NM_018206.6(VPS35):c.151G>A (p.Gly51Ser) AND Parkinson disease 17

Germline classification:
Benign (2 submissions)
Last evaluated:
Nov 19, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000577720.18

Allele description [Variation Report for NM_018206.6(VPS35):c.151G>A (p.Gly51Ser)]

NM_018206.6(VPS35):c.151G>A (p.Gly51Ser)

Gene:
VPS35:VPS35 retromer complex component [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16q11.2
Genomic location:
Preferred name:
NM_018206.6(VPS35):c.151G>A (p.Gly51Ser)
HGVS:
  • NC_000016.10:g.46682127C>T
  • NG_029970.1:g.12106G>A
  • NM_018206.6:c.151G>AMANE SELECT
  • NP_060676.2:p.Gly51Ser
  • NC_000016.9:g.46716039C>T
  • NM_018206.4:c.151G>A
  • NM_018206.5:c.151G>A
Protein change:
G51S
Links:
dbSNP: rs193077277
NCBI 1000 Genomes Browser:
rs193077277
Molecular consequence:
  • NM_018206.6:c.151G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Parkinson disease 17 (PARK17)
Identifiers:
MONDO: MONDO:0013625; MedGen: C3280133; Orphanet: 411602; OMIM: 614203

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000679654GeneReviews
no classification provided
not providedgermlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV001019988Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Benign
(Nov 19, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, literature only

Citations

PubMed

VPS35-Related Parkinson Disease..

Dulski J, Ross OA, Wszolek ZK.

2017 Aug 10 [updated 2023 Mar 23]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024.

PubMed [citation]
PMID:
28796472

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group, Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From GeneReviews, SCV000679654.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001019988.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 24, 2024